Cathie Wood: portfolio of ARK Investment Management
Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.
Source: 13F filing with the US Securities and Exchange Commission dated Jul 10, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2023. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 15.1B USD
- Positions
- 222
- Share of the ten largest
- 49.0%
The ten largest positions Q2 2023
- Tesla, Inc. 8.4%▼ −11.0%
- Coinbase 5.7%▲ +2.9%
- UiPath Inc 5.3%▲ +7.5%
- Roku Inc 5.1%▼ −4.2%
- Block, Inc. 4.7%▲ +2.4%
- Zoom Video Communications Inc 4.7%▼ −3.7%
- Exact Sciences Corp 4.4%▼ −37.1%
- Shopify 3.8%▼ −36.5%
- Unity Software Inc 3.4%▼ −3.0%
- Teladoc Health Inc 3.4%▼ −1.2%
Show all positions of this quarter
Choose a quarter (40 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
All positions Q2 2023
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| TSLA Tesla, Inc. | 8.4% | 4,843,621 | 1.3B USD | −11.0% reduced | Q4 2016 or earlier 27 quarters |
| Roku Inc | 5.1% | 11,958,292 | 764.9M USD | −4.2% reduced | Q2 2019 17 quarters |
| Zoom Video Communications Inc | 4.7% | 10,462,306 | 710.2M USD | −3.7% reduced | Q4 2020 11 quarters |
| Exact Sciences Corp | 4.4% | 7,155,098 | 671.9M USD | −37.1% reduced | Q3 2020 12 quarters |
| SHOP Shopify | 3.8% | 8,874,796 | 573.3M USD | −36.5% reduced | Q2 2017 25 quarters |
| Unity Software Inc | 3.4% | 11,935,740 | 518.2M USD | −3.0% reduced | Q3 2020 12 quarters |
| Teladoc Health Inc | 3.4% | 20,344,101 | 515.1M USD | −1.2% reduced | Q3 2017 24 quarters |
| DKNG DraftKings | 3.2% | 18,060,463 | 479.9M USD | −24.5% reduced | Q1 2021 10 quarters |
| CRISPR Therapeutics AG | 2.7% | 7,338,447 | 412.0M USD | −8.2% reduced | Q2 2017 25 quarters |
| Intellia Therapeutics Inc | 2.6% | 9,525,931 | 388.5M USD | −3.2% reduced | Q4 2016 or earlier 27 quarters |
| Pacific Biosciences of Califor | 2.3% | 26,634,620 | 354.2M USD | −4.0% reduced | Q3 2019 16 quarters |
| Beam Therapeutics Inc | 1.8% | 8,382,595 | 267.7M USD | −2.2% reduced | Q4 2020 11 quarters |
| Veracyte Inc | 1.3% | 7,828,292 | 199.4M USD | −6.9% reduced | Q4 2016 or earlier 27 quarters |
| Schrodinger Inc/United States | 1.2% | 3,517,355 | 175.6M USD | −10.0% reduced | Q2 2020 13 quarters |
| 10X Genomics Inc | 1.2% | 3,113,549 | 173.9M USD | −25.1% reduced | Q2 2020 13 quarters |
| Twist Bioscience Corp | 0.9% | 6,959,240 | 142.4M USD | −3.1% reduced | Q2 2019 17 quarters |
| NVDA Nvidia | 0.8% | 295,732 | 125.1M USD | −28.6% reduced | Q4 2016 or earlier 27 quarters |
| Grayscale Bitcoin Trust BTC | 0.7% | 5,820,591 | 111.7M USD | −5.1% reduced | Q4 2018 19 quarters |
| Ionis Pharmaceuticals Inc | 0.7% | 2,422,631 | 99.4M USD | −8.1% reduced | Q4 2016 or earlier 27 quarters |
| Accolade Inc | 0.5% | 5,683,906 | 76.6M USD | −1.0% reduced | Q3 2020 12 quarters |
| CareDx Inc | 0.4% | 6,638,350 | 56.4M USD | −2.4% reduced | Q2 2019 17 quarters |
| Arcturus Therapeutics Holdings | 0.4% | 1,906,996 | 54.7M USD | −4.0% reduced | Q2 2019 17 quarters |
| MELI MercadoLibre | 0.3% | 43,594 | 51.6M USD | −26.7% reduced | Q4 2016 or earlier 27 quarters |
| Cerus Corp | 0.3% | 20,657,391 | 50.8M USD | −6.5% reduced | Q4 2016 or earlier 27 quarters |
| DE Deere & Company | 0.3% | 117,018 | 47.4M USD | −5.3% reduced | Q3 2017 24 quarters |
| Global-e Online Ltd | 0.3% | 1,081,123 | 44.3M USD | −8.2% reduced | Q1 2022 6 quarters |
| Komatsu Ltd | 0.3% | 1,559,264 | 42.2M USD | −0.1% reduced | Q3 2019 16 quarters |
| VRTX Vertex Pharmaceuticals | 0.3% | 115,671 | 40.7M USD | −4.0% reduced | Q3 2020 12 quarters |
| VEEV Veeva Systems | 0.3% | 200,394 | 39.6M USD | −3.9% reduced | Q4 2020 11 quarters |
| Adyen NV | 0.2% | 21,551 | 37.3M USD | −0.1% reduced | Q1 2019 18 quarters |
| 2U Inc | 0.2% | 8,783,754 | 35.4M USD | −5.8% reduced | Q4 2016 or earlier 27 quarters |
| INTU Intuit | 0.2% | 71,541 | 32.8M USD | −0.1% reduced | Q2 2017 25 quarters |
| BILL Holdings Inc | 0.2% | 276,201 | 32.3M USD | −0.1% reduced | Q1 2021 10 quarters |
| Discovery Ltd | 0.2% | 4,102,370 | 31.8M USD | −0.1% reduced | Q4 2019 15 quarters |
| Genius Sports Ltd | 0.2% | 5,088,781 | 31.5M USD | −0.4% reduced | Q3 2021 8 quarters |
| NU Nu Holdings (Class A) | 0.2% | 3,934,538 | 31.0M USD | −7.8% reduced | Q4 2021 7 quarters |
| INCY Incyte | 0.2% | 467,566 | 29.1M USD | −35.8% reduced | Q4 2016 or earlier 27 quarters |
| StoneCo Ltd | 0.2% | 2,240,437 | 28.5M USD | −5.1% reduced | Q2 2021 9 quarters |
| GOOG Alphabet Inc. (Class C) | 0.2% | 233,254 | 28.2M USD | −2.5% reduced | Q2 2020 13 quarters |
| Stratasys Ltd | 0.2% | 1,578,513 | 28.0M USD | −12.1% reduced | Q4 2016 or earlier 27 quarters |
| Repare Therapeutics Inc | 0.2% | 2,628,073 | 27.8M USD | −4.0% reduced | Q4 2020 11 quarters |
| 908 Devices Inc | 0.2% | 3,972,905 | 27.3M USD | −0.5% reduced | Q4 2020 11 quarters |
| Elbit Systems Ltd | 0.2% | 118,897 | 24.8M USD | −12.3% reduced | Q4 2016 or earlier 27 quarters |
| ANSYS Inc | 0.2% | 74,407 | 24.6M USD | −6.6% reduced | Q4 2016 or earlier 27 quarters |
| REGN Regeneron Pharmaceuticals | 0.2% | 32,253 | 23.2M USD | −4.0% reduced | Q4 2020 11 quarters |
| Guardant Health Inc | 0.1% | 574,995 | 20.6M USD | −1.4% reduced | Q3 2022 4 quarters |
| Compass Pathways Plc | 0.1% | 2,439,580 | 20.2M USD | −4.0% reduced | Q3 2022 4 quarters |
| MSFT Microsoft | 0.1% | 58,969 | 20.1M USD | −13.4% reduced | Q4 2016 or earlier 27 quarters |
| ISRG Intuitive Surgical | 0.1% | 52,065 | 17.8M USD | −8.6% reduced | Q2 2018 21 quarters |
| MRNA Moderna | 0.1% | 142,998 | 17.4M USD | −4.0% reduced | Q3 2022 4 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 135 positions.
Breakdown by sector
- Financials 12.6%
- Consumer Discretionary 8.6%
- Technology 7.4%
- Health Care 1.3%
- Industrials 1.2%
- Communication Services 0.6%
- not in our coverage 68.4%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors